Welcome to In Vivo’s new AI-focused blog, BioBytes, providing news and insight on the growing role of artificial intelligence in biopharma. Moderna is teaming up with IBM to integrate quantum computing into its operations. The partnership should accelerate and optimize drug discovery and development while continuing to evolve Moderna's digital-first approach.
Moderna, Inc. is maintaining its position at the head of the pack of early tech adopters. The mRNA-focused biotech is partnering with IBM to prepare its workforce to integrate quantum computing into operations.
“It's about preparedness,” Wade Davis, VP of computational science at Moderna, told In Vivo. “We're taking the approach much like...
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.
